Fresenius alleges ‘blatant fraud at the very top level’ of Akorn operations

7th May 2018 Uncategorised 0

Fresenius continues to hammer Akorn with allegations of fraud in its drug development and manufacturing as the German company battles to extract itself from its $4.3 billion buyout of the U.S. sterile injectables maker.

More: Fresenius alleges ‘blatant fraud at the very top level’ of Akorn operations
Source: fierce